Click here to jump to the main content
National Drug Policy New Zealand Home.

National Drug Policy New Zealand

Print this   Email this

Publications

Pemoline: Expert Advisory Committee on Drugs Advice to the Minister

Date of publication: Oct 2002

This paper considers the central nervous system stimulant pemoline - a substance that has been used to treat attention deficit disorder overseas. It has also been abused in some countries because of its amphetamine-like stimulant effects (Marnell 1999).

Pemoline is not controlled under the Misuse of Drugs Act 1975 (the Act). This assessment proposes that the Expert Advisory Committee on Drugs (EACD) considers recommending to the Minister of Health that pemoline be classified as a Third Schedule (Class C) Part 5 controlled drug.

Document availability

This publication is available in PDF format.

EACD advice on Pemoline (PDF, 157 KB)